Alder BioPharmaceuticals® Presents New Data on Migraine-Free Months, Migraine Severity and Quality of Life, Demonstrating Eptinezumab’s Clinical Profile for Migraine Prevention July 11, 2019 - NASDAQ Companies 0 » View More News for July 11, 2019